chr14-24575410-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001911.3(CTSG):c.58G>A(p.Glu20Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000149 in 1,614,116 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001911.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CTSG | NM_001911.3 | c.58G>A | p.Glu20Lys | missense_variant, splice_region_variant | 2/5 | ENST00000216336.3 | |
CTSG | XM_011536499.2 | c.100G>A | p.Glu34Lys | missense_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CTSG | ENST00000216336.3 | c.58G>A | p.Glu20Lys | missense_variant, splice_region_variant | 2/5 | 1 | NM_001911.3 | P1 | |
CTSG | ENST00000552252.1 | n.85G>A | splice_region_variant, non_coding_transcript_exon_variant | 2/4 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000211 AC: 53AN: 250990Hom.: 0 AF XY: 0.000170 AC XY: 23AN XY: 135664
GnomAD4 exome AF: 0.000145 AC: 212AN: 1461818Hom.: 0 Cov.: 32 AF XY: 0.000149 AC XY: 108AN XY: 727226
GnomAD4 genome AF: 0.000190 AC: 29AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.58G>A (p.E20K) alteration is located in exon 2 (coding exon 2) of the CTSG gene. This alteration results from a G to A substitution at nucleotide position 58, causing the glutamic acid (E) at amino acid position 20 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at